101
|
Studying restoration of brain function with fetal tissue grafts: Optimal models. Behav Brain Sci 1995. [DOI: 10.1017/s0140525x0003750x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
AbstractWe concur that basic research on the use of CNS grafts is needed. Two important model systems for functional studies of grafts are ignored by Stein & Glasier. In the first, reproductive function is restored in hypogonadal mice by transplantation of GnRH-synthesizing neurons. In the second, circadian rhythmicity is restored by transplantation of the suprachiasmatic nucleus.
Collapse
|
102
|
Gene replacement therapy in the CNS: A view from the retina. Behav Brain Sci 1995. [DOI: 10.1017/s0140525x00037493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
AbstractGene replacement therapy holds great promise in the treatment of many genetic CNS disorders. This commentary discusses the feasibility of gene replacement therapy in the unique context of the retina, with regard to: (1) the genetics of retinal neoplasia and degeneration, (2) available gene transfer technology, and (3) potential gene delivery vehicles.
Collapse
|
103
|
The limitations of central nervous systemdirected gene transfer. Behav Brain Sci 1995. [DOI: 10.1017/s0140525x0003733x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
AbstractComplementation and correction of a genetic defect with CNS manifestations lags behind gene therapy for inherited disorders affecting other organ systems because of shortcomings in delivery vehicles and access to the CNS. The effects of improvements in viral and nonviral vectors, coupled with the development of delivery strategies designed to transfer genetic material thoughout the CNS are being investigated by a number of laboratories in efforts to overcome these problems.
Collapse
|
104
|
CNS transplant utility may surive even their hasty clinical application. Behav Brain Sci 1995. [DOI: 10.1017/s0140525x00037444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
AbstractNeural cell transplants have been introduced in clinical practice during the last decade with mixed results, encouraged by success with simple animal models. This commentary is a reminder that although the ideas and techniques of transplantation appear simple, the variables involved in host-transplant integration still require further study. The field may benefit from a concerted, multidisciplinary approach.
Collapse
|
105
|
Are fetal brain tissue grafts necessary for the treatment of brain damage? Behav Brain Sci 1995. [DOI: 10.1017/s0140525x00037596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
AbstractDespite some clinical promise, using fetal transplants for degenerative and traumatic brain injury remains controversial and a number of issues need further attention. This response reexamines a number of questions. Issues addressed include: temporal factors relating to neural grafting, the role of behavioral experience in graft outcome, and the relationship of rebuilding of neural circuitry to functional recovery. Also discussed are organization and type of transplanted tissue, the “trophic hypothesis” of transplant viability, and whether transplants are really needed to obtain functional recovery after brain damage.
Collapse
|
106
|
Transplantation, plasticity, and the aging host. Behav Brain Sci 1995. [DOI: 10.1017/s0140525x00037377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
AbstractNeural transplantation as a recovery strategy for neuro-degenerative diseases in humans has used mainly grafting following acute denervation strategies in young adult hosts. Our work in aged mice and rats demonstrates an age-related increase in susceptibility to oxidative damage from neurotoxins, a remarkably poor recovery of C57BL/6 mice from MPTP insult with transplantation and growth factors, even at 12 months of age, and diminished plasticity of host neurons. We believe that extrapolation of data from young adult animal models to aged humans without thorough investigation of transplantation and host response inagedrecipients is scientifically and ethically inappropriate.
Collapse
|
107
|
Tai IT, Vacek I, Sun AM. The alginate-poly-L-lysine-alginate membrane: Evidence of a protective effect on microencapsulated islets of Langerhans following exposure to cytokines. Xenotransplantation 1995. [DOI: 10.1111/j.1399-3089.1995.tb00064.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
108
|
Abstract
Cells encapsulated in a semi-permeable polymer membrane display enhanced viability and proliferation when sequestered along with a supportive matrix. In the present study, anionic sodium alginate and cationic chitosan were used as supportive matrices to study their influence on the growth of both anchorage dependent and independent cell types. A phaeochromocytoma-derived cell line, PC12, and two fibroblast cell lines, R208F and R208N.8, were encapsulated in sodium alginate microcapsules, crosslinked chitosan microcapsules and 60:40 acrylonitrile-vinylchloride copolymer (PAN/PVC) macrocapsules containing precipitated chitosan as an internal matrix. Microcapsules were maintained for 2 wk in vitro and macrocapsules were maintained for 4 wk. Both the PC12 and the R208F cells proliferated in the alginate microcapsules. Catecholamine release was detected from PC12 cell-loaded microcapsules. In contrast, the R208N.8 cells were not supported by the alginate and the only viable R208N.8 cells seen in this system protruded from the alginate matrix into the surrounding cationic poly-l-lysine lamina. All three cell lines grew poorly in crosslinked chitosan microcapsules yet they exhibited excellent viability when sequestered in PAN/PVC macrocapsules containing an internal matrix of precipitated chitosan. Significant catecholamine levels were detected from macroencapsulated PC12 cells while macroencapsulated R208N.8 cells released nerve growth factor (NGF) as demonstrated by a qualitative bioassay. This study shows that a cationic hydrogel, precipitated chitosan, supports attachment and spreading of fibroblasts when used as a matrix in the lumen of a PAN/PVC macrocapsule.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- B A Zielinski
- Section of Artificial Organs, Biomaterials and Cellular Technology, Brown University, Providence RI
| | | |
Collapse
|
109
|
Emerich DF, McDermott PE, Krueger PM, Winn SR. Intrastriatal implants of polymer-encapsulated PC12 cells: effects on motor function in aged rats. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18:935-46. [PMID: 7972863 DOI: 10.1016/0278-5846(94)90109-0] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
1. The feasibility of ameliorating the motor deficits in aged rats was evaluated in animals receiving polymer-encapsulated PC12 cells. 2. Motor coordination and balance was evaluated in young (5-6 month) and aged (24-25 month) rats. Compared to the young animals, the aged animals fell more rapidly from a rotating rod and were unable to maintain their balance on a series of wooden beams of varying widths. 3. Following baseline testing, aged animals received either no implant, empty capsules or PC12 cell-loaded capsules implanted bilaterally into the striatum. 4. Three weeks following surgery, animals were re-tested and a significant improvement in balance on the rotorod and wooden beams was observed in those aged animals receiving PC12 cell-loaded capsules. No improvements or decrements in performance were observed in those animals receiving empty. Histological analysis revealed the presence of surviving tyrosine hydroxylase-positive PC12 cells randomly distributed within the capsules.
Collapse
|
110
|
Herman JP, Abrous ND. Dopaminergic neural grafts after fifteen years: results and perspectives. Prog Neurobiol 1994; 44:1-35. [PMID: 7831470 DOI: 10.1016/0301-0082(94)90055-8] [Citation(s) in RCA: 66] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- J P Herman
- CNRS UMR 9941, Laboratoire des Interactions Cellulaires Neuroendocriniennes, Faculté de Médecine Nord, Marseille, France
| | | |
Collapse
|
111
|
Menei P, Benoit JP, Boisdron-Celle M, Fournier D, Mercier P, Guy G. Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres. Neurosurgery 1994; 34:1058-64; discussion 1064. [PMID: 8084391 DOI: 10.1227/00006123-199406000-00016] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
Controlled drug release in the central nervous system through an implantable polymeric vector has been developed in recent years. For this purpose, different polymeric devices composed primarily of synthetic biocompatible and biodegradable polymers have been investigated. The first polymeric devices developed were macroscopic implants (monolithic devices), which required open surgery for implantation. Microencapsulation methods, however, allow the production of microparticles or nanoparticles loaded with neuroactive drugs. Because of their size, these micro- or nanoparticles may be easily implanted by stereotaxy in discrete, precise, and functional areas of the brain without causing damage to the surrounding tissue. Presently, this method is most frequently applied in the fields of neuro-oncology and neurodegenerative diseases, but neurologically, the potential applications of drug targeting by stereotactic implantation of drug-loaded particles are legion.
Collapse
Affiliation(s)
- P Menei
- Service de Neurochirurgie, Centre Hospitalo-Universitaire, Angers, France
| | | | | | | | | | | |
Collapse
|
112
|
Abstract
It is very likely that genetic therapies will soon be established for a number of diseases and injuries of the central nervous system. The targets for these therapies will not only be the underlying causative genes, but also neurotrophic factors that affect the survival and function of neurons as well as aberrant secondary metabolic and neurotransmitter functions.
Collapse
Affiliation(s)
- T Friedmann
- Center for Molecular Genetics, School of Medicine, University of California at San Diego, La Jolla 92093
| |
Collapse
|
113
|
Menei P, Benoit JP, Boisdron-Celle M, Fournier D, Mercier P, Guy G. Drug Targeting into the Central Nervous System by Stereotactic Implantation of Biodegradable Microspheres. Neurosurgery 1994. [DOI: 10.1097/00006123-199406000-00016] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Affiliation(s)
- Philippe Menei
- Service de Neurochirurgie, Centre Hospitalo-Universitaire, Université d'Angers, Angers, France
| | - Jean-Pierre Benoit
- Laboratoire de Pharmacie Galénique et Biophysique Pharmaceutique, Faculté de Pharmacie, Université d'Angers, Angers, France
| | - Michelle Boisdron-Celle
- Laboratoire de Pharmacie Galénique et Biophysique Pharmaceutique, Faculté de Pharmacie, Université d'Angers, Angers, France
| | - Dominique Fournier
- Service de Neurochirurgie, Centre Hospitalo-Universitaire, Université d'Angers, Angers, France
| | - Philippe Mercier
- Service de Neurochirurgie, Centre Hospitalo-Universitaire, Université d'Angers, Angers, France
| | - Gilles Guy
- Service de Neurochirurgie, Centre Hospitalo-Universitaire, Université d'Angers, Angers, France
| |
Collapse
|
114
|
Bellamkonda R, Aebischer P. Review: Tissue engineering in the nervous system. Biotechnol Bioeng 1994; 43:543-54. [DOI: 10.1002/bit.260430703] [Citation(s) in RCA: 60] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
115
|
Wu MP, Tamada JA, Brem H, Langer R. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH 1994; 28:387-95. [PMID: 8077254 DOI: 10.1002/jbm.820280314] [Citation(s) in RCA: 79] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Intracranial studies to analyze the degradation kinetics of the bioerodible polymer poly[bis(p-carboxyphenoxy)propane-sebacic acid] [p(CPP-SA) 20:80] copolymer wafers were conducted in a rat model. Rats were separated into four groups: those receiving 1) polymer, 2) polymer loaded with the chemotherapeutic agent BCNU, 3) drug-loaded polymer with previous tumor implantation, and 4) polymer and an absorbable hemostatic material. A polymer wafer was surgically implanted into the brain of each animal. Residual polymer was harvested at varying times for chromatographic analysis. In vitro effects of pH, mixing, and water availability on degradation were also studied. The results of in vitro and in vivo studies were compared to understand the behavior of polymers in a clinical setting. We found that degradation of p(CPP-SA) initially occurred more slowly in vivo than in vitro. The presence of BCNU, tumor, and absorbable hemostatic material did not affect the ultimate time of polymer degradation in vivo, and the intrinsic polymer degradation time of 1 mm thick p(CPP-SA) 20:80 disks in vivo was 6-8 weeks.
Collapse
Affiliation(s)
- M P Wu
- Harvard-M.I.T. Division of Health Sciences and Technology, Cambridge 02139
| | | | | | | |
Collapse
|
116
|
Abstract
Tissue from human fetal cadavers has long been used for medical research, experimental therapies, and various other purposes. Research within the last two decades has led to substantial progress in many of these areas, particularly in the application of fetal tissue transplantation to the treatment of human disease. As a result, clinical trials have now been initiated at centers around the world to evaluate the use of human fetal tissue transplantation for the therapy of Parkinson's disease, insulin-dependent diabetes mellitus, and a number of blood, immunological and, metabolic disorders. Laboratory studies suggest a much wider range of disorders may in the future be treatable by transplantation of various types of human fetal tissue. A combination of characteristics renders fetal tissue uniquely valuable for such transplantation, as well as for basic research, the development of vaccines, and a range of other applications. Although substitutes for human fetal tissue are being actively sought, for many of these applications there are at present no satisfactory alternatives. Important issues remain unresolved concerning the procurement, distribution, and use of human fetal cadaver tissue as well as the effects of such use on abortion procedures and incidence. These issues can be addressed by the introduction of appropriate guidelines or legislation, and need not be an impediment to legitimate research and therapeutic use of fetal tissue.
Collapse
Affiliation(s)
- A Fine
- Department of Physiology and Biophysics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
| |
Collapse
|
117
|
Tresco P. Encapsulated cells for sustained neurotransmitter delivery to the central nervous system. J Control Release 1994. [DOI: 10.1016/0168-3659(94)90172-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
118
|
Hydrogel Applications for Encapsulated Cellular Transplants. ACTA ACUST UNITED AC 1994. [DOI: 10.1016/b978-0-12-185291-7.50029-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register]
|
119
|
|
120
|
Jaeger CB, Aebischer P, Tresco PA, Winn SR, Greene LA. Growth of tumour cell lines in polymer capsules: ultrastructure of encapsulated PC12 cells. JOURNAL OF NEUROCYTOLOGY 1992; 21:469-80. [PMID: 1500946 DOI: 10.1007/bf01186951] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Recent studies indicate that polymer-encapsulated PC12 cells release sufficient amounts of dopamine to significantly alter behavioural paradigms in animals with unilateral lesions of dopaminergic midbrain neurons. Because cell fine structure provides a useful measure for assessment of storage function, exocytosis, metabolism, cell activity and cell viability, we examined the ultrastructure of PC12 cells grown in semi-permeable polymer capsules maintained in vitro or implanted into the forebrain of rats or guinea pigs. Encapsulated PC12 cells remained viable and continued to divide for the entire evaluation period of six months. Overall morphologies of encapsulated PC12 cells were similar in both environments and they resembled PC12 cells grown in monolayer cultures. In short-term cultures, encapsulated PC12 cells typically contained abundant quantities of chromaffin cell-like granules. The encapsulated cells had initially abundant microvilli on their surfaces which decline in frequency over time. After long-term enclosure for ten weeks or more, fewer secretory granules were detected in the cytoplasm of cells in capsules cultured in vitro and in brain-implanted capsules. Some cells in implanted capsules had long slender filipodia that were not present on PC12 cells in cultured capsules. The morphological changes of PC12 cells may correlate with altered growth conditions such as serum and oxygen concentrations, the presence or absence of growth factors in different environments, and with changes of cell interactions related to cell densities and build up of debris within the capsules over time. Since dopaminergic PC12 pheochromocytoma cells remain viable in semi-permeable polymer capsules for at least six months, such 'cell-capsules' could provide an alternative to dopamine-secreting embryonic neural grafts in dopamine replacement therapies.
Collapse
Affiliation(s)
- C B Jaeger
- Department of Anatomy, Purdue University, School of Veterinary Medicine, West Lafayette, IN 47907
| | | | | | | | | |
Collapse
|
121
|
Christenson L, Emerich DF, Sanberg PR. Encapsulated cell implantation for Parkinson's disease. Mov Disord 1992; 7:185-6. [PMID: 1584240 DOI: 10.1002/mds.870070215] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
|
122
|
Emerich DF, Winn SR, Christenson L, Palmatier MA, Gentile FT, Sanberg PR. A novel approach to neural transplantation in Parkinson's disease: use of polymer-encapsulated cell therapy. Neurosci Biobehav Rev 1992; 16:437-47. [PMID: 1480340 DOI: 10.1016/s0149-7634(05)80185-x] [Citation(s) in RCA: 88] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Transplantation of dopaminergic neurons derived from fetal or adrenal tissue into the striatum is a potentially useful treatment for Parkinson's disease (PD). Although initially promising, recent clinical studies using adrenal autografts have demonstrated limited efficacy. The use of human fetal cells, despite promising preliminary results, is complicated by tissue availability and ethical concerns. An attractive alternative is based on encapsulating dopamine-producing cells into polymer capsules prior to transplantation. Polymer capsules can be fabricated to surround the cells with a semi-permeable and immunoprotective barrier. The semi-permeable membrane allows nutrients to enter the capsule, so the encapsulated cells will survive and function, and dopamine and other low molecular weight constituents to diffuse out into the host tissue. Thus, the technique allows use of unmatched human tissue (allografts), or even animal tissue (xenografts) without immunosuppression of the recipient. Cell-loaded polymer capsules can also be retrieved if necessary or desired. The demonstration that striatal implants of encapsulated dopamine-producing cells promote behavioral recovery in rodent and primate models of PD further suggests that cellular encapsulation may be a useful strategy for ameliorating the behavioral consequences of PD.
Collapse
Affiliation(s)
- D F Emerich
- CytoTherapeutics, Inc., Providence, RI 02906
| | | | | | | | | | | |
Collapse
|
123
|
Aebischer P, Tresco PA, Sagen J, Winn SR. Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats. Brain Res 1991; 560:43-9. [PMID: 1760745 DOI: 10.1016/0006-8993(91)91212-j] [Citation(s) in RCA: 63] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Surrounding bovine chromaffin cells by a semipermeable membrane may protect the transplanted cells from a host immune response and shield them from the inflammatory process resulting from the surgical trauma. Encapsulation of the chromaffin cells was achieved by interfacial adsorption of a polycation on a polyanionic colloid matrix in which the chromaffin cells were entrapped. Basal and potassium-evoked release of catecholamines from encapsulated bovine chromaffin cells was analyzed over a 4-week period in vitro. Norepinephrine and dopamine release remained constant over time whereas epinephrine release significantly decreased. The chromaffin cells also retained the capacity for depolarization-elicited catecholamine release 4 weeks following the encapsulation procedure. Morphological analysis revealed the presence of intact chromaffin cells with well-preserved secretory granules. Striatal implantation of chromaffin cell-loaded capsules significantly reduced apomorphine-induced rotation compared to empty polymer capsules in animals lesioned with 6-hydroxydopamine for at least 4 weeks. Intact chromaffin cells expressing tyrosine hydroxylase and dopamine-beta-hydroxylase were observed in all capsules implanted in the striatum for 4 weeks. The assessment of the clinical potential of transplanting encapsulated adrenal chromaffin cells of either allo- or xenogeneic origin for Parkinson's disease will require long-term behavioral studies. The present study suggests, however, that the polymer encapsulation procedure may offer an alternative to adrenal autografts as a source of dopaminergic tissue.
Collapse
Affiliation(s)
- P Aebischer
- Section for Artificial Organs, Biomaterials and Cellular Technology, Brown University, Providence, RI
| | | | | | | |
Collapse
|